Vagus Nerve Stimulation
Conditions
Keywords
Vagus Nerve Stimulations, Diastolic Pressure, Pulse Rate, Systolic Pressure
Brief summary
Transcutaneous Auricular Vagus nerve stimulation may be successful in cardiac modulation because of the cardiac connections of the vagal nerve. Therefore, in order to observe the cardiac effects, it was analysed the changes in pulse rate, systolic and diastolic blood pressure after transcutaneous auricular vagus nerve stimulation application.
Detailed description
Participants were divided into four groups (Figure 1) according to PNS and SNS indexes as Group 1 (PNS index \<-2, SNS index \>+2), Group 2 (PNS index \<-2, SNS index \<+2), Group 3 (PNS index \>-2, SNS index \>+2), Group 4 (PNS index \>-2, SNS index \<+2). Participants were assessed with blood pressure, pulse rate and HRV before and after taVNS stimulation. Sympathetic nervous system (SNS) index and parasympathetic nervous system (PNS) index values were assumed to be between -2 and +2 (95%) in the normal population according to Kubios software, and the grouping method was based on this situation.
Interventions
DEVICETranscutaneous Auricular Vagus Nerve Stimulation
Through a special Ear set, bilateral Transcutaneous Auricular Vagus Nerve Stimulation was applied to all participants for 20 minutes.
Sponsors
Bahçeşehir University
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
The evaluations were carried out by the second researcher
Intervention model description
After the participants were included in the study, heart rate variability was measured and divided into 4 groups according to PNS and SNS indexes.
Eligibility
Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* Age between 18 and 40 years old. * No previous vagus nerve stimulation
Exclusion criteria
* Using of any drug, alcohol or smoking. * Pregnancy. * Known history of acute or chronic illness. * Being in the post or peri-menopausal stage.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pulse Rate | Up to 6 Months | The pulse rate of the participants was measured with an electronic blood pressure monitor. |
| Systolic Blood Pressure | Up to 6 Months | The systolic blood pressure of the participants was measured with an electronic blood pressure monitor. |
| Diastolic Blood Pressure | Up to 6 Months | The diastolic blood pressure of the participants was measured with an electronic blood pressure monitor. |
Countries
Turkey (Türkiye)
Outcome results
None listed